Home
>
National Drug Code (NDC)
>
Kayexalate
Kayexalate - 0024-1075-01 - (sodium polystyrene sulfonate)
Drug Information of Kayexalate
| Product NDC: | 0024-1075 |
| Proprietary Name: | Kayexalate |
| Non Proprietary Name: | sodium polystyrene sulfonate |
| Active Ingredient(s): | 4.1 meq/g & nbsp; sodium polystyrene sulfonate |
| Administration Route(s): | ORAL; RECTAL |
| Dosage Form(s): | POWDER, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Kayexalate
| Product NDC: | 0024-1075 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA011287 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19580108 |
Package Information of Kayexalate
| Package NDC: | 0024-1075-01 |
| Package Description: | 453.6 g in 1 JAR (0024-1075-01) |
NDC Information of Kayexalate
| NDC Code | 0024-1075-01 |
| Proprietary Name | Kayexalate |
| Package Description | 453.6 g in 1 JAR (0024-1075-01) |
| Product NDC | 0024-1075 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sodium polystyrene sulfonate |
| Dosage Form Name | POWDER, FOR SUSPENSION |
| Route Name | ORAL; RECTAL |
| Start Marketing Date | 19580108 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | SODIUM POLYSTYRENE SULFONATE |
| Strength Number | 4.1 |
| Strength Unit | meq/g |
| Pharmaceutical Classes |
